1. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β‐catenin pathway
    Jiancang Ma et al, 2019, Journal of Cellular Physiology CrossRef
  2. Genetical modification on adipose-derived stem cells facilitates facial nerve regeneration
    Jian Tan et al, 2019, Aging CrossRef
  3. IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin
    Yarong Guo et al, 2021, Translational Oncology CrossRef
  4. Unraveling the role of Xist RNA in cardiovascular pathogenesis
    Waleed Hassan Almalki, 2024, Pathology - Research and Practice CrossRef
  5. miR-449a Suppresses LDHA-Mediated Glycolysis to Enhance the Sensitivity of Non-Small Cell Lung Cancer Cells to Ionizing Radiation
    Liang Li et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
  6. LncRNA SNHG7 sponges miR-449a to promote pituitary adenomas progression
    Xiongfei Yue et al, 2021, Metabolic Brain Disease CrossRef
  7. MicroRNA-497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3
    Juhua Zhuang et al, 2017, Molecular Medicine Reports CrossRef
  8. Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway
    Nan-Fang Luo et al, 2024, Heliyon CrossRef
  9. Activation of the ROCK1/MMP-9 pathway is associated with the invasion and poor prognosis in papillary thyroid carcinoma
    Dingyuan Luo et al, 2017, International Journal of Oncology CrossRef
  10. MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment
    Maria Papaioannou et al, 2022, Frontiers in Oncology CrossRef
  11. GABRB2 plays an important role in the lymph node metastasis of papillary thyroid cancer
    Yixiang Jin et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  12. MicroRNA‑449b‑3p inhibits epithelial‑mesenchymal transition by targeting IL‑6 and through the JAK2/STAT3 signaling pathway in non‑small cell lung cancer
    Kai Cai et al, 2020, Experimental and Therapeutic Medicine CrossRef